Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Wa'el Hashad
|
| gptkbp:clinicalTrialPhase |
gptkb:Alzheimer's_disease
hypoplastic left heart syndrome aging-related frailty |
| gptkbp:developedBy |
Lomecel-B
|
| gptkbp:focusesOn |
regenerative medicine
cell-based therapies |
| gptkbp:foundedYear |
2014
|
| gptkbp:founder |
gptkb:Geoffrey_Green
Joshua M. Hare |
| gptkbp:headquartersLocation |
gptkb:Miami,_Florida,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Longeveron Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockSymbol |
gptkb:LGVN
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
https://www.longeveron.com/
|
| gptkbp:bfsParent |
gptkb:LGNX
|
| gptkbp:bfsLayer |
7
|